Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Mustea

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
International Journal of Surgery (London, England)|February 24, 2025
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysisFabian Trillsch, Bastian Czogalla, Sven Mahner, et al.
Annals of Surgical Oncology|March 16, 2021
Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 StudyLinn Woelber, Mareike Bommert, Philipp Harter, et al.
Journal of the National Cancer Institute|January 26, 2015
Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 studySven Mahner, Julia Jueckstock, Felix Hilpert, et al.
Gynecologic Oncology|February 15, 2019
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 studyStephan Polterauer, Richard Schwameis, Christoph Grimm, et al.
Pharmaceutics|September 23, 2022
Non-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A First-In-Human Feasibility StudyCas Stefaan Dejonckheere, Adriana Torres-Crigna, Julian Philipp Layer, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2017
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) ConsortiumIlary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
Gynecologic Oncology|November 19, 2021
Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 studyLinn Woelber, Katharina Prieske, Christine Zu Eulenburg, et al.
Annals of Surgical Oncology|September 10, 2022
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) ConsortiumJacek Glajzer, Dan Cacsire Castillo-Tong, Rolf Richter, et al.
Journal of Cancer Research and Clinical Oncology|July 25, 2024
Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approachAlexander Mustea, Damian J Ralser, Eva K Egger, et al.
Gynecologic Oncology|March 2, 2021
Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 studyKatharina Prieske, Linn Woelber, Mustafa Zelal Muallem, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Surgery (London, England)|February 24, 2025
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysisFabian Trillsch, Bastian Czogalla, Sven Mahner, et al.
Annals of Surgical Oncology|March 16, 2021
Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 StudyLinn Woelber, Mareike Bommert, Philipp Harter, et al.
Journal of the National Cancer Institute|January 26, 2015
Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 studySven Mahner, Julia Jueckstock, Felix Hilpert, et al.
Gynecologic Oncology|February 15, 2019
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 studyStephan Polterauer, Richard Schwameis, Christoph Grimm, et al.
Pharmaceutics|September 23, 2022
Non-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A First-In-Human Feasibility StudyCas Stefaan Dejonckheere, Adriana Torres-Crigna, Julian Philipp Layer, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2017
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) ConsortiumIlary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
Gynecologic Oncology|November 19, 2021
Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 studyLinn Woelber, Katharina Prieske, Christine Zu Eulenburg, et al.
Annals of Surgical Oncology|September 10, 2022
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) ConsortiumJacek Glajzer, Dan Cacsire Castillo-Tong, Rolf Richter, et al.
Journal of Cancer Research and Clinical Oncology|July 25, 2024
Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approachAlexander Mustea, Damian J Ralser, Eva K Egger, et al.
Gynecologic Oncology|March 2, 2021
Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 studyKatharina Prieske, Linn Woelber, Mustafa Zelal Muallem, et al.
Pageof 18